Suppr超能文献

单核细胞趋化蛋白-1(MCP-1)和成纤维细胞生长因子-21(FGF-21)作为女性亚临床动脉粥样硬化的生物标志物。

Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.

机构信息

Health Research Coordination, Centro Medico Nacional, Instituto Mexicano del Seguro Social (IMSS), Mexico.

School of Rehabilitation Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

出版信息

Exp Gerontol. 2019 Sep;124:110624. doi: 10.1016/j.exger.2019.05.013. Epub 2019 May 29.

Abstract

BACKGROUND

Atherosclerosis is a primary risk factor for cardiovascular disease (CVD). Proinflammatory biochemical factors can influence vascular health; monocyte chemoattractant protein-1 (MCP-1) is elevated in patients with CVD while fibroblast growth factor-21 (FGF-21) acts directly on cardiac tissue to reduce infarction damage. However, the relationship between plasma concentrations of MCP-1, FGF-21 and subclinical CVD indices remains equivocal.

AIM

To determine the association between MCP-1, FGF-21 and subclinical atherosclerosis [i.e., carotid intima-media thickness (cIMT)] in women without clinical evidence of CVD.

METHODS

A cross-sectional analysis of 140 women without history of CVD was performed. Anthropometrics were collected, serum concentrations of MCP-1 and FGF-21 were determined by enzyme-linked immunosorbent assay, and cIMT was quantified (B-mode ultrasonography). The correlations between MCP-1, FGF-21 and the presence of clinical and laboratory of subclinical atherosclerosis (i.e., cIMT ≥0.70 mm), comparison intergroup and odd ratio with multiple logistic regression were analyzed.

RESULTS

MCP-1, but not FGF-21 correlated with some obesity indicators. In median comparison among groups, subclinical atherosclerosis showed higher serum concentrations of MCP-1and lower serum concentrations of FGF-21. In postmenopausal women, there were significant differences MCP-1 (p = 0.001), and FGF-21 (p = 0.010). Multiple logistic regression analysis in postmenopausal women with subclinical atherosclerosis, between MCP-1 (p = 0.001) and FGF-21 (p = 0.037) showed association with cIMT, along with age.

CONCLUSIONS

MCP-1 and FGF-21 levels are associated with subclinical atherosclerosis disease severity (i.e., cIMT) in postmenopausal women without CVD. Further efforts focused on characterizing the relationship between novel blood-borne markers of early CVD pathology are warranted and should be pursued.

摘要

背景

动脉粥样硬化是心血管疾病(CVD)的主要危险因素。促炎生化因子会影响血管健康;单核细胞趋化蛋白-1(MCP-1)在 CVD 患者中升高,而成纤维细胞生长因子-21(FGF-21)则直接作用于心脏组织,减少梗塞损伤。然而,血浆 MCP-1、FGF-21 浓度与亚临床 CVD 指标之间的关系仍存在争议。

目的

确定无 CVD 临床证据的女性中 MCP-1、FGF-21 与亚临床动脉粥样硬化(即颈动脉内膜中层厚度[cIMT])之间的关系。

方法

对 140 名无 CVD 病史的女性进行横断面分析。收集人体测量学数据,通过酶联免疫吸附试验测定 MCP-1 和 FGF-21 的血清浓度,并通过 B 型超声量化 cIMT。分析 MCP-1、FGF-21 与临床和实验室亚临床动脉粥样硬化(即 cIMT≥0.70mm)之间的相关性,并通过多元逻辑回归进行组间比较和比值比分析。

结果

MCP-1 而不是 FGF-21 与一些肥胖指标相关。在组间中位数比较中,亚临床动脉粥样硬化表现出更高的血清 MCP-1 浓度和更低的血清 FGF-21 浓度。在绝经后妇女中,MCP-1(p=0.001)和 FGF-21(p=0.010)存在显著差异。在绝经后亚临床动脉粥样硬化妇女的多元逻辑回归分析中,MCP-1(p=0.001)和 FGF-21(p=0.037)与 cIMT 相关,同时与年龄相关。

结论

MCP-1 和 FGF-21 水平与无 CVD 的绝经后妇女亚临床动脉粥样硬化疾病严重程度(即 cIMT)相关。进一步努力描述早期 CVD 病理新型血液标志物之间的关系是必要的,应予以推进。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验